Document 0049
 DOCN  M9620049
 TI    Regulating controversial programs for unpopular people: methadone
       maintenance and syringe exchange programs [see comments]
 DT    9602
 AU    Des Jarlais DC; Paone D; Friedman SR; Peyser N; Newman RG; Beth Israel
       Medical Center, New York City, USA.
 SO    Am J Public Health. 1995 Nov;85(11):1577-84. Unique Identifier :
       AIDSLINE MED/96036593
 CM    Comment in: Am J Public Health 1995 Nov;85(11):1490-1
 AB    One third of all cases of the acquired immunodeficiency syndrome (AIDS)
       in the United States are associated with the injection of illicit drugs.
       There is mounting evidence for the effectiveness of syringe exchange
       programs in reducing human immunodeficiency virus (HIV) risk behavior
       and HIV transmission among injection drug users. Expansion of syringe
       exchange would require increased public funding and undoubtedly would
       include government regulation of syringe exchanges. An analogy is drawn
       with the present system of regulation of methadone maintenance treatment
       programs and possible regulation of syringe exchange programs. Specific
       recommendations are offered to reduce the likelihood of repeating the
       regulatory problems of methadone maintenance treatment in future
       regulation of syringe exchange programs.
 DE    Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL  Drug and
       Narcotic Control/HISTORY  History of Medicine, 20th Cent.  Human
       Methadone/HISTORY/*THERAPEUTIC USE  Needle-Exchange
       Programs/*LEGISLATION & JURISPRUD  Public Health/*TRENDS  Substance
       Abuse Treatment Centers/LEGISLATION & JURISPRUD/*TRENDS  Substance
       Abuse, Intravenous/*REHABILITATION  Support, Non-U.S. Gov't  United
       States  HISTORICAL ARTICLE  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).